MEDx

About:

MEDx provides precision medicine solutions to improve clinical development.

Top Investors: Qiming Venture Partners, Quan Capital, Sinopharm Capital, Qingsong Capital, CTS Capital

Description:

MEDx provides precision medicine solutions to improve clinical development. Its services use translational science for diagnostic technology of nucleic acid and protein. It also offers biomarker development, Companion Diagnostics (CDx), Point-of-Care (POC) development, clinical testing, and commercialization. The company was founded in 2013 and is headquartered in Suzhou, Jiangsu.

Total Funding Amount:

350M CNY

Headquarters Location:

Suzhou, Jiangsu, China

Founded Date:

2013-01-01

Contact Email:

MARKETING(AT)MEDxTMC.com

Founders:

Number of Employees:

Last Funding Date:

2020-09-28

IPO Status:

Private

Industries: